Thu.Dec 15, 2022

article thumbnail

340B program continues to drive shift in care to more expensive hospital settings

PhRMA

Yet another study highlights the unintended consequences of the 340B program, which is increasing costs for patients and the health care system as a whole. In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals 286
article thumbnail

Three Trends Shaping HIV Pharmacy Care

Pharmacy Times

Although quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.

131
131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: AbbVie exits major pharmaceutical industry lobbying groups

STAT

WASHINGTON — The maker of one of the world’s most profitable medicines is exiting the pharmaceutical industry’s two major lobbying organizations next year, just as Washington pledges to crack down on high drug costs. AbbVie, which for years has fought off competition for its blockbuster autoimmune drug Humira — the world’s top-selling medicine before Pfizer’s Covid-19 vaccine hit the market — has been the target of congressional hearings and legis

Vaccines 113
article thumbnail

Pharmacies Poised to Capture At-Home Diagnostics Category

Pharmacy Times

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Inflation caused another big drop in net drug prices, analysis finds

STAT

Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name drugmakers increased their wholesale prices by 4.8% in the third quarter this year, up slightly from 4.2% a year earlier and 4.9% in the previous quarter. But when accounting for inflation, wholesale prices fell by 3.1%, and inflationary pressures are likely to push wholesale prices still higher.

107
107
article thumbnail

Direct-acting Antivirals for Hepatitis C Infection Are Underused in the US, Study Finds

Pharmacy Times

While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.

123
123

More Trending

article thumbnail

Prevalence and Types of Myelodysplastic Syndromes (MDS)

Pharmacy Times

Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding myelodysplastic syndrome (MDS).

138
138
article thumbnail

NICE backs use of Boehringer’s Ofev in IPF from diagnosis

pharmaphorum

Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim’s Ofev, following new guidance from health technology assessment agency NICE. Ofev (nintedanib) has been recommended since 2015 for NHS use in IPF patients who have a forced vital capacity (FVC) value of 50% to 80% of normal, but will now be an option for people with less severe disease, i.e. an FVC of more than 80%.

Labelling 105
article thumbnail

Future-Proofing Pharmacies Amid a Changing Health Care Landscape

Pharmacy Times

New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.

127
127
article thumbnail

STAT+: Amid criticism over unaffordable insulin, Lilly strikes a manufacturing deal to supply Africa

STAT

In a bid to widen access to insulin in primarily low-income nations in Africa, Eli Lilly has agreed to sell active pharmaceutical ingredients and transfer technology to an Egyptian company that expects to supply the life-saving diabetes treatment to as many as 1 million people by 2030. The 10-year agreement calls for Lilly to sell the ingredients needed to manufacture both human and analogue insulin at a “significantly reduced” price to EVA Pharma and also provide “pro bono&

105
105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Mental Health Status and Access to Services Are Key Issues for LGBTQ+ Patients

Drug Topics

When dealing with marginalized and underserved populations, it is important to understand barriers to care and why they exist.

98
article thumbnail

The evolving role of social media in healthcare

pharmaphorum

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. In addition, many organisations are now also using social media for non-accredited medical education, social listening, and facilitation of networking and best practice sharing.

article thumbnail

Strep A kills three more children as UK activates alternative medicines plan

The Guardian - Pharmaceutical Industry

At least 19 children have died and scarlet fever cases are more than treble what they were in previous high season Three more children have died from strep A, it has emerged, and pharmacists in the UK have been told they can supply alternative antibiotics to those originally prescribed, in a bid to ease shortages of certain forms of penicillin. The UK Health Security Agency (UKHSA) data shows at least 19 children have now died across the UK, while there are 7,750 cases of scarlet fever so far th

98
article thumbnail

FDA Finalizes Guidance Re Enforcement Policy for Homeopathic Drugs

The FDA Law Blog

By Riëtte van Laack — On December 7, 2022, FDA announced the availability of the final guidance regarding the enforcement policy for homeopathic drug products. This concludes FDA’s reevaluation of the regulation of homeopathic drugs which it started in 2015. As we reported previously, here , and here , as a result of the growth of the industry and safety issues, in 2015 FDA started the reevaluation of its regulatory framework for homeopathic products.

FDA 98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Eisai and Washington University to develop neurodegenerative disease therapies

Pharmaceutical Technology

Eisai has entered a comprehensive research partnership agreement with Washington University School of Medicine in St Louis, US, to develop potential new therapies for neurodegenerative ailments. Under the deal, the parties intend to develop treatments for diseases including Alzheimer’s and Parkinson’s. The alliance will merge the capabilities of the scientists at Washington University in the basic and clinical research in neurodegenerative ailments, such as dementia, with the wide-ranging expert

article thumbnail

Chief health equity officers are growing more common. But experts say companies need to empower them

STAT

A string of high-profile health companies like Teladoc and CVSHealth have hired their first chief health equity officers this year as the industry grapples with troubling health disparities. But the people in these prominent positions — and the ones hiring them — say they’re still defining the role, and in some cases, fighting for buy-in and resources from others in their organizations.

98
article thumbnail

The Benefits of Pharmig Membership in 2023

Pharmig

In the pharmaceutical, healthcare, cosmetics, and NHS industries, Pharmig is a non-profit professional organisation that promotes the interests of people who work in, are in charge of, or collaborate with microbiology. It was founded in 1991. The post The Benefits of Pharmig Membership in 2023 appeared first on Pharmig.

98
article thumbnail

Science, Cell issue notices of concern on challenged papers co-authored by Stanford president

STAT

The leading journals Science and Cell on Thursday issued “expressions of concern” on papers co-authored by Stanford University president Marc Tessier-Lavigne, who is under investigation over allegations of research misconduct. Tessier-Lavigne, a neuroscientist, is facing scrutiny over allegations of altered images in at least five papers he worked on going back two decades, including two papers published in Science and one in Cell.

98
article thumbnail

Examining the Impact of CBD on Plasma Endocannabinoid Levels

Drug Topics

Research examines how cannabidiol impacts plasma endocannabinoid when consumed along with delta-9-tetrahydrocannabinol.

98
article thumbnail

STAT+: Biden administration takes aim at Medicare Advantage care denials, misleading ads

STAT

The Biden administration has unveiled its plan for attacking people’s chief concerns about privatized Medicare for older adults: care denials and scammy ads. The agency that runs Medicare said it received almost 4,000 comments on how to improve the popular Medicare Advantage program starting in 2024, when it’s expected to cover the majority of Medicare beneficiaries.

article thumbnail

Southeastern Grocers opens Winn-Dixie store in Jacksonville, Fla.

Drug Store News

The new store, located in a suburb of its hometown of Jacksonville, is the first of three new Winn-Dixie stores the grocer is opening to support economic growth in its communities.

96
article thumbnail

STAT+: Drugmakers ask regulators to change standards on new Covid antibody drugs for most vulnerable

STAT

Biotech executives and a handful of academics pleaded with U.S. and European regulators on Thursday to adopt new standards for approving antibody drugs against Covid, particularly for immunocompromised and other vulnerable patients. The four-hour hearing came as agencies, companies, and researchers face a fundamental mismatch: The virus is evolving faster than our ability to develop interventions under normal — or even normal emergency — procedures.

FDA 98
article thumbnail

Mental Health Telemedicine Barriers Spur Call for Reform

Drug Topics

With increasing use of telehealth, patients need access to resources that let them get the most out of the experience.

98
article thumbnail

Watch DSN: PQS’ Sega shines a light on its EQUIPP® platform

Drug Store News

DSN spoke with Todd Sega, CEO of Pharmacy Quality Solutions, about the company’s new platform and how it helps pharmacies shift toward quality measurement and performance.

98
article thumbnail

Opinion: Fixing price instability can improve access to affordable prescription drugs

STAT

The high cost of prescription drugs is a very real problem in the United States. The average American spends approximately $1,300 per year on prescription drugs, more than residents of any other country in the world. And for some new medications, it seems the sky’s the limit when it comes to cost. For people in marginalized and traditionally underserved communities, in which chronic medical conditions such as diabetes, obesity, and respiratory diseases are more widespread, the problem can

98
article thumbnail

How Drug Shortages Are Prevented by the FDA

Drug Topics

With supply chain issues impacting many industries, drug shortages have occurred. How does the FDA address them?

FDA 98
article thumbnail

STAT+: Guardant Health trial of colon cancer liquid biopsy test disappoints observers

STAT

Bay Area biotech Guardant Health on Thursday announced results from a massive trial of its blood-based test for the early detection of colon cancer that, while good enough for Medicare reimbursement, underwhelmed observers. The company announced that a study of more than 20,000 people, dubbed ECLIPSE, detected colon cancer 83% of the time it was actually there and correctly returned a negative result 90% of the time — characteristics of a test known as sensitivity and specificity, respect

98
article thumbnail

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access. zbecker. Thu, 12/15/2022 - 10:51.

110
110
article thumbnail

Health officials revise BMI tool to track severe obesity in kids

STAT

U.S. health officials have revised a tool to track the rising cases of severe obesity among children who were previously off the charts. Updated growth charts released Thursday by the Centers for Disease Control and Prevention now extend to a body mass index of 60 — up from previous charts that stopped at a BMI of 37, with additional categories to track obesity in kids ages 2 to 19.

98
article thumbnail

Risk Factors for Developing MDS

Pharmacy Times

Medical experts provide an overview on potential risk factors leading to MDS.

132
132
article thumbnail

At least 24 hospitals, providers have been targeted online and offline over gender-affirming care, report says

Fierce Healthcare

At least 24 hospitals, providers have been targeted online and offline over gender-affirming care, report says. dmuoio. Thu, 12/15/2022 - 11:36.

Hospitals 104
article thumbnail

5 Ways to Prepare for a Successful 2023 at Your Pharmacy

Digital Pharmacist

The role of pharmacies is somewhat changed compared to one in the past. People used to consider the pharmacy as a place to fill their prescriptions, but, pharmacies and pharmacists do much more than prepare medications. Most people fill their medication and medicinal devices from their local community pharmacies. To outstand and succeed among the other pharmacies, community pharmacies should find a way to distinguish their pharmacy from others.

article thumbnail

Genetic testing lab owner convicted in $463M Medicare fraud case

Fierce Healthcare

Genetic testing lab owner convicted in $463M Medicare fraud case. fdiamond. Thu, 12/15/2022 - 14:14.

124
124
article thumbnail

AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer

Fierce Pharma

AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer. kdunleavy. Thu, 12/15/2022 - 09:53.

FDA 103